ANGO vs MKTX · rev $292.5M vs P/E 13, rev $817.1M
AngioDynamics Inc (ANGO) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
ANGO currently screens at market cap $378.5M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the ANGO and MKTX stock pages for the full models.
Not investment advice.